Search
News
Downloads
About
Help
Contact
Entity Details
Primary name
REPS2_HUMAN
Entity type
UniProt
Source
Source Link
Details
Accession
Q8NFH8
EntryName
REPS2_HUMAN
FullName
RalBP1-associated Eps domain-containing protein 2
TaxID
9606
Evidence
evidence at protein level
Length
660
SequenceStatus
complete
DateCreated
2003-08-15
DateModified
2021-06-02
Ontological Relatives
Genes
REPS2
GO terms
Show/Hide Table
GO
Name
GO:0005509
calcium ion binding
GO:0005829
cytosol
GO:0006897
endocytosis
GO:0007173
epidermal growth factor receptor signaling pathway
GO:0016197
endosomal transport
GO:0061024
membrane organization
GO:0065003
protein-containing complex assembly
Subcellular Location
Show/Hide Table
Subcellular Location
Cytoplasm
Domains
Show/Hide Table
Domain
Name
Category
Type
IPR000261
EH domain
Domain
Domain
IPR002048
EF-hand domain
Domain
Domain
IPR011992
EF-hand domain pair
Family
Homologous superfamily
IPR018247
EF-Hand 1, calcium-binding site
Site
Binding site
Diseases
Show/Hide Table
Drugs
Show/Hide Table
Interactions
17 interactions
Interactor
Partner
Sources
Publications
Link
REPS2_HUMAN
EPN1_HUMAN
BioGRID, HPRD, MINT
10557078
10764745
15809337
9422736
details
REPS2_HUMAN
TPC2L_HUMAN
MINT
21827752
details
REPS2_HUMAN
REPS1_HUMAN
BioGRID, HPRD, IntAct
28514442
9422736
details
REPS2_HUMAN
RBP1_HUMAN
BioGRID, HPRD, IntAct
28514442
9422736
details
REPS2_HUMAN
GRB2_HUMAN
BioGRID, HPRD
18647389
9422736
details
REPS2_HUMAN
EPS15_HUMAN
BioGRID, HPRD
10393179
details
REPS2_HUMAN
ANDR_HUMAN
BioGRID
15604093
details
REPS2_HUMAN
CDK1_HUMAN
BioGRID
10764745
details
REPS2_HUMAN
ASAP1_HUMAN
HPRD
12149250
details
REPS2_HUMAN
TF65_HUMAN
HPRD
15184881
details
REPS2_HUMAN
CK5P2_HUMAN
HPRD
15184881
details
REPS2_HUMAN
AMPH_HUMAN
BioGRID
18647389
details
REPS2_HUMAN
AP2A1_HUMAN
BioGRID
10764745
details
REPS2_HUMAN
MYO6_HUMAN
BioGRID
26950368
details
REPS2_HUMAN
RALB_HUMAN
HPRD
9422736
details
REPS2_HUMAN
PAXI_HUMAN
HPRD
12149250
details
REPS2_HUMAN
ASAP2_HUMAN
HPRD
12149250
details
This website requires cookies in order to function. By using the site you are agreeing to this as outlined in our
Terms of Use
I Agree